Kate Harnden
Overview
Explore the profile of Kate Harnden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harnden K, Di Matteo A, Howell K, Mankia K
BMJ Case Rep
. 2024 Apr;
17(4).
PMID: 38663895
Immune checkpoint inhibitors have revolutionised the treatment of cancer. While very effective, they commonly cause a wide spectrum of immune-related adverse events. These immune-related adverse events can be fatal and...
2.
Garcia-Montoya L, Kang J, Duquenne L, Di Matteo A, Nam J, Harnden K, et al.
Lancet Rheumatol
. 2024 Jan;
6(2):e72-e80.
PMID: 38267105
Background: Subclinical synovitis occurs in a third of individuals at risk of rheumatoid arthritis. The objective of this study was to assess the reversibility of subclinical synovitis in individuals at...
3.
Di Matteo A, De Lorenzis E, Duquenne L, Nam J, Garcia-Montoya L, Harnden K, et al.
Rheumatology (Oxford)
. 2023 Nov;
63(8):2213-2221.
PMID: 37934127
Objectives: To investigate, in anti-CCP antibody-positive individuals with musculoskeletal symptoms but no clinical synovitis (CCP+ at-risk), the additional value of US for the prediction of inflammatory arthritis. Furthermore, to define...
4.
Duquenne L, Hensor E, Wilson M, Garcia-Montoya L, Nam J, Wu J, et al.
Ann Intern Med
. 2023 Jul;
176(8):1027-1036.
PMID: 37523695
Background: Inflammatory arthritis (IA) is an immune-related condition defined by the presence of clinical synovitis. Its most common form is rheumatoid arthritis. Objective: To develop scores for predicting IA in...
5.
Harnden K, Di Matteo A, Mankia K
Front Med (Lausanne)
. 2022 Dec;
9:1058510.
PMID: 36507546
In recent years rheumatologists have begun to shift focus from early rheumatoid arthritis (RA) to studying individuals at risk of developing the disease. It is now possible to use blood,...
6.
Gul H, Harnden K, Saleem B
Healthcare (Basel)
. 2021 Dec;
9(12).
PMID: 34946453
It is now accepted that the optimum treatment goal for rheumatoid arthritis (RA) is sustained remission, as this has been shown to be associated with the best patient outcomes. There...
7.
Vandevelde C, Harnden K, Freeston J, Barr A, Selinger C, Shams K, et al.
Rheumatology (Oxford)
. 2020 Nov;
60(1):467-470.
PMID: 33200190
No abstract available.
8.